WSGR logoWSGR logo
Aaron B. Gordon
Associate
Corporate Governance
Boston

D617-598-7839

Download vCard
Open PDF

Aaron B. Gordon is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a part of the firm’s corporate practice.

During law school, Aaron was a summer associate and law clerk in Wilson Sonsini’s Boston office, where he assisted in representation of early-stage life sciences companies.

Experience

Aaron B. Gordon is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a part of the firm’s corporate practice.

During law school, Aaron was a summer associate and law clerk in Wilson Sonsini’s Boston office, where he assisted in representation of early-stage life sciences companies.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Cognite, Major Shareholders on $3.1 Billion Sale to Schneider Electric
On June 30, 2026, Aker ASA (Aker) and the other shareholders of Cognite announced that they have entered into an agreement to sell 100 percent of the shares in Cognite Holding B.V. (Cognite) to Schneider Electric based on an enterprise value of US$3.1 billion. Wilson Sonsini Goodrich & Rosati’s cross-border tech M&A team advised Cognite and its major shareholders, including Aker, TCV, and Accel, on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Cognito Therapeutics on Oversubscribed $105 Million Series C
On March 5, 2026, Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, announced the closing of an oversubscribed $105 million Series C financing round. Wilson Sonsini Goodrich & Rosati advised Cognito Therapeutics on the transaction.
Learn More
View All
WSGR logo
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.